Consistent with the rights and incentives provided by the Bayh–Dole Act of 1980, US universities have increased their involvement in patenting and licensing activities through their own technology transfer offices. Only a few US universities are obtaining large returns, however, whereas others are continuing with these activities despite negligible or negative returns. We assess the US universities’ potential to generate returns from licensing activities by modeling and estimating quantiles of the distribution of net licensing returns conditional on some of their structural characteristics. We find limited prospects for public universities without a medical school everywhere in their distribution. Other groups of universities (private, and public with a medical school) can expect better but still fairly modest returns. These findings call into question the appropriateness of the revenue-generating motive for the aggressive rate of patenting and licensing by US universities.
No takes yet. Share an insight, caveat, or question.
Bulut et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: